The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...

The SOUL protocol had participants randomized 1:1 to oral semaglutide (starting at 3 mg and escalated to 14 mg ... Participants were told to take their assigned tablet in the morning, with a ...

Researchers randomly assigned patients to receive oral semaglutide gradually titrated to the maximal, 14-mg dose or placebo on ... group (incidence rate, 3.1 events per 100 person-years) and ...

Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...

Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being ...

Novo Nordisk markets its semaglutide medicines as Ozempic pre-filled pens and Rybelsus oral tablets ... mg achieved a superior weight loss of 18.7% compared to a reduction of 15.6% with Wegovy and ...

Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...

of infections and infestations leading to treatment discontinuation (versus 63 [1.3%] with oral semaglutide 14 mg). 1,2 Based on data from the SOUL clinical trial, Novo Nordisk submitted a label ...

Among participants, 59% had a BMI <30 kg/m2, lower than many studies with semaglutide. Testing was conducted on a constant-load treadmill with fixed speed (3.2 km/hr ... semaglutide at a maximum dose ...

Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults with type 2 diabetes. A regulatory decision is anticipated in 2025. Rybelsus, ...